Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Harriman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Analytical Chemistry|January 15, 2004
An interface for direct analysis of (14)c in nonvolatile samples by accelerator mass spectrometryRosa G Liberman, Steven R Tannenbaum, Barbara J Hughey, et al.
Journal of Clinical Pharmacology|February 26, 2013
Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: volume of distribution at steady stateFranco Lombardo, Nigel J Waters, Upendra A Argikar, et al.
Journal of Clinical Pharmacology|February 26, 2013
Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearanceFranco Lombardo, Nigel J Waters, Upendra A Argikar, et al.
Current Drug Metabolism|June 25, 2005
A comprehensive listing of bioactivation pathways of organic functional groupsAmit S Kalgutkar, Iain Gardner, R Scott Obach, et al.
Journal of Medicinal Chemistry|March 4, 2008
Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesisDaniel S La, Julie Belzile, James V Bready, et al.
Journal of Medicinal Chemistry|March 8, 2008
Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitorsMatthew M Weiss, Jean-Christophe Harmange, Anthony J Polverino, et al.
Journal of Medicinal Chemistry|March 8, 2008
Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluationJean-Christophe Harmange, Matthew M Weiss, Julie Germain, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Analytical Chemistry|January 15, 2004
An interface for direct analysis of (14)c in nonvolatile samples by accelerator mass spectrometryRosa G Liberman, Steven R Tannenbaum, Barbara J Hughey, et al.
Journal of Clinical Pharmacology|February 26, 2013
Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: volume of distribution at steady stateFranco Lombardo, Nigel J Waters, Upendra A Argikar, et al.
Journal of Clinical Pharmacology|February 26, 2013
Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearanceFranco Lombardo, Nigel J Waters, Upendra A Argikar, et al.
Current Drug Metabolism|June 25, 2005
A comprehensive listing of bioactivation pathways of organic functional groupsAmit S Kalgutkar, Iain Gardner, R Scott Obach, et al.
Journal of Medicinal Chemistry|March 4, 2008
Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesisDaniel S La, Julie Belzile, James V Bready, et al.
Journal of Medicinal Chemistry|March 8, 2008
Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitorsMatthew M Weiss, Jean-Christophe Harmange, Anthony J Polverino, et al.
Journal of Medicinal Chemistry|March 8, 2008
Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluationJean-Christophe Harmange, Matthew M Weiss, Julie Germain, et al.
Pageof 2